Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
42.12%
EBIT Growth (5y)
-9.73%
EBIT to Interest (avg)
-4.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.00
Sales to Capital Employed (avg)
7.29
Tax Ratio
1.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
0.28
EV to EBITDA
0.28
EV to Capital Employed
1.48
EV to Sales
-0.48
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
524.73%
ROE (Latest)
-603.65%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 73.23%
PRE-TAX PROFIT(Q)
At SEK -0.34 MM has Grown at 63.69%
NET PROFIT(Q)
At SEK -0.34 MM has Grown at 65.44%
-25What is not working for the Company
INTEREST(9M)
At SEK 0.57 MM has Grown at inf%
NET SALES(HY)
At SEK 2.93 MM has Grown at -78.83%
NET PROFIT(HY)
At SEK -2.9 MM has Grown at -229.36%
OPERATING CASH FLOW(Y)
Lowest at SEK -6.67 MM
ROCE(HY)
Lowest at -257.56%
RAW MATERIAL COST(Y)
Grown by 81.01% (YoY
Here's what is working for ODI Pharma AB
Inventory Turnover Ratio
Highest at 73.23% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Pre-Tax Profit
At SEK -0.34 MM has Grown at 63.69%
over average net sales of the previous four periods of SEK -0.94 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
At SEK -0.34 MM has Grown at 65.44%
over average net sales of the previous four periods of SEK -0.99 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
Here's what is not working for ODI Pharma AB
Net Sales
At SEK 2.93 MM has Grown at -78.83%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (SEK MM)
Interest
At SEK 0.57 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Operating Cash Flow
Lowest at SEK -6.67 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (SEK MM)
Raw Material Cost
Grown by 81.01% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
